Farms.com Home   News

BQA Issues For The Beef Cow-Calf Producer

Beef cow-calf producers have consistently improved the quality of beef from cull cows and bulls. Over the past two decades the beef industry has conducted quality assurance audits for cull cows and bulls. Every concern has been addressed and producers have decreased quality defects of most quality measures.
 
Beef from cull cows selling as whole muscle cuts has increased over the years as opposed to hamburger. Consequently the value of cull cows has improved as quality defects have decreased with lower incidents of bruising and injections site lesions.
 
One area of concern that continues to be an issue is the occurrence of violative drug residue. The beef cattle industry has not been able to eliminate this vital defect. The USDA National Residue Program indicates that beef cows continue to be detected with violative drug residues at a rate of 0.5-0.7 percent. That may seem like a small number but that’s five head per 1000.
 
Violative drug residues have stayed consistent over the past decade. Unfortunately most of these incidences are due to careless management. Cow-calf producers need to keep better records and pay careful attention at shipping time. Most violations are from antibiotics, anti-inflammatory products and anthelmintics. There is no good excuse for violating drug withdrawal times. Many violations probably occur while cows are being processed in the fall. A cow receives a deworming product in the chute before she’s identified as open. These violations are a small percentage of the entire industry but the industry needs to concentrate on driving violation rates to zero. Educators at Michigan State University Extension recommend that producers be diligent in their health recording keeping and animal tracking systems.
 

Trending Video

Leman Swine Conference: Vaccination strategies to reduce PRRS virus recombination

Video: Leman Swine Conference: Vaccination strategies to reduce PRRS virus recombination

Dr. Jay Calvert, Research Director with Zoetis, recently spoke to The Pig Site’s Sarah Mikesell at the 2023 Leman Swine Conference in St. Paul, Minnesota, USA, about his conference presentation on porcine reproductive and respiratory syndrome (PRRS) virus recombination.

“The number one problem in PRRS these days from a vaccine point of view is the emergence of new strains of PRRS. Since the beginning, we have had new strains and a lot of diversity,” said Dr. Jay Calvert. “We thought we knew it was all about mutation changes in amino acids and the individual strains over time, but they take on new characteristics.”

With the onset of more common whole genome sequencing and recombination analysis, Dr. Calvert says there is another mechanism, and recombination seems to be a key factor.